{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-092676","form_type":"8-K","ticker":"NTRB","cik":"0001676047","company_name":"NutriBand Inc.","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.194049+00:00","generated_at":"2026-05-30T07:29:08.399308+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Nutriband receives Chinese patent for AVERSA abuse-deterrent transdermal system","bullets":["CNIPA fully issued Patent No. ZL 202211158031 for 'Abuse and Misuse Deterrent Transdermal System' related to AVERSA technology.","Patent covers taste aversion to prevent abuse of opioid patches; previously allowed in September 2024.","AVERSA IP portfolio now includes granted patents in US, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China.","Lead product under development is an abuse-deterrent fentanyl patch incorporating AVERSA technology."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-092676","json":"https://secwatch.observer/filing/0001213900-24-092676.json","markdown":"https://secwatch.observer/filing/0001213900-24-092676.md","text":"https://secwatch.observer/filing/0001213900-24-092676.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676047/000121390024092676/0001213900-24-092676-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676047/000121390024092676/ea0219429-8k_nutriband.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:29:08.399308+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}